Risa Wong is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 55 publications with 781 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AmgenProgram year20251 paymentResearch$183,315openpaymentsdata.cms.gov ↗
- Exelixis Inc.Program year20242 payments
- Eisai Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
69.5%Cytochrome P450 17A1 Inhibitor20%Abiraterone Acetate100%Part D≥11 patientsGonadotropin Releasing Hormone Receptor Antagonist16.5%Orgovyx100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
22.8%Corticosteroid18.2%Prednisone100%Part D≥25 patientsSerotonin-3 Receptor Antagonist4.5%Ondansetron Hcl100%Part D≥15 patientsSensory organs
4%Corticosteroid4%Dexamethasone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Characterizing Pain and Opioid-Related Risks in Individuals With Advanced Cancer: A Cohort Study
Journal of Pain and Symptom Management
2026 - Androgen Deprivation Therapy for Prostate Cancer and Quality of Life: A Concept Map Analysis
SSRN Electronic Journal
2026 - Androgen deprivation therapy and quality of life: A concept map analysis.
Journal of Clinical Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Norman Wolmark, MD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Udai Kammula, MD
University of Pittsburgh
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”